Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Operating Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Operating Profit (Excl OI) ₹30 Cr₹20 Cr₹20 Cr₹1,655,282 Cr₹17 Cr

What is the latest Operating Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Operating Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹30 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹30 Cr
Mar2024₹20 Cr
Mar2023₹20 Cr
Mar2022₹1,655,282 Cr
Mar2017₹17 Cr

How is Operating Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Operating Profit % Change
Mar2025 ₹30 Cr
48.98
Mar2024 ₹20 Cr
-0.67
Mar2023 ₹20 Cr
-100.00
Mar2022 ₹1,655,282 Cr
9,930,201.10
Mar2017 ₹17 Cr -

Compare Operating Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,315.1 Cr 2.4% 2.2% -35.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,639.0 Cr 1.4% -4.5% 6.5% Stock Analytics
DIVIS LABORATORIES ₹179,647.0 Cr 0.1% -2.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,366.0 Cr -2.7% 1.2% 39.3% Stock Analytics
CIPLA ₹109,528.0 Cr -2.3% -5.3% -9.8% Stock Analytics
DR REDDYS LABORATORIES ₹105,819.0 Cr -0.5% -4.7% -5.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

2.4%

2.2%

-35.4%

SENSEX

4.9%

2.8%

-6.2%


You may also like the below Video Courses